Mov Disord Vol 33, Suppl 2 Archives - Page 93 of 177 - MDS Abstracts

2018 International Congress
Cortical correlates of dual-task turning with and without freezing of gait
M. Mancini, S. Stuart (Portland, OR, USA)
Objective: This study investigated the relationship between prefrontal cortex (PFC) activity and turning characteristics with and without a dual-task in in people with Parkinson’s disease…
2018 International Congress
Erotophonophilia and severe impulse control disorder in a patient with Parkinson’s disease
C. vander Linden, H. Colle, D. Colle, J. Jankovic (Ghent, Belgium)
Objective: N/A Background: Paraphilia a form of hyper sexuality is a rare complication of dopaminergic drugs used in the treatment of Parkinson's disease (PD). We…
2018 International Congress
Depression and associated factors in nondemented Chinese patients with Parkinson’s disease
J. Zhu, L. Zhang (Nanjing, China)
Objective: This study aimed to estimate the prevalence and identify potential risk factors influencing depression in 519 consecutive nondemented Chinese PD patients. Background: Depression is…
2018 International Congress
Assessing the Quality of Economic Evaluation of Treatment Options for Parkinson’s disease Using the Quality of Health Economic Studies (QHES) Scale
M. Azharuddin, M. Adil, P. Ghosh, M. Sharma (New Delhi, India)
Objective: The objective of this study was to critically appraise all the published evidences on the economic evaluation of treatment options for Parkinson’s disease. Background:…
2018 International Congress
Are the MDS-UPDRS-based composite scores clinically applicable?
N. Kovács, A. Juhász, Z. Aschermann (Pécs, Hungary)
Objective: Our aim is to evaluate the feasibility of various composite scores based on the Movement Disorder Society-sponsored Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) as…
2018 International Congress
Ankle proprioception and postural instability in Parkinson’s disease
H. Teasdale, E. Preston, W. Spratford, G. Waddington (Bruce, Australia)
Objective: To determine: 1. Is there a correlation between central and peripheral proprioception in Parkinson’s disease? 2. Does postural instability increase with lack of vision…
2018 International Congress
Linking neuroplastic effects to behavioral changes after balance training in Parkinson’s disease: a study protocol of a randomized controlled trial
E. Franzén, H. Johansson, M. Freidle, U. Ekman, E. Schalling, A. Lebedev, M. Lövdén, S. Holmin, P. Svenningsson, M. Hagströmer (Huddinge, Sweden)
Objective: In this randomized controlled trial, we will determine the effects of a highly challenging balance training (the HiBalance program) on balance, gait, cognition and…
2018 International Congress
PPMI driven sample size estimation for clinical trials in Parkinson’s disease
K. Marek, J. Seibyl, C. Caspell-Garcia, C. Coffey, B. Mollenhauer, K. Kieburtz, C. Tanner, L. Chahine, A. Siderowf, T. Simuni (New Haven, CT, USA)
Objective: To utilize clinical, imaging and CSF data from the Parkinson’s Progression Markers Initiative (PPMI) to estimate the sample size for disease modification studies in…
2018 International Congress
The relationship between family care giver number and progression speed of dementia
Y. Liu, S.L. Yang, Y.C. Wu (Shanghai, China)
Objective: Study the fact delays dementia progression. Background: Alzheimer’s disease is unrestored yet now. Relieving the life upset of patient and postponing the disease progression…
2018 International Congress
Assessing the Effectiveness of Valbenazine in the Treatment of Tardive Dyskinesia as Determined by the AIMS and PGIC: Results from the KINECT 4 Trial
C. Singer, C. Comella, K. Farahmand, J. Burke, R. Jimenez, S. Siegert (Miami, FL, USA)
Objective: To assess the long-term effects of once-daily valbenazine on tardive dyskinesia (TD). Background: Valbenazine has been evaluated in several long-term TD studies, including the…